Nasdaq (Nasdaq: NDAQ) reports that the annual review of its Nordic market capitalization (market cap) segments is completed. The revision is based on the average market cap value in November 2014. Together with indexes and sector classifications, the market cap segmentation is a tool to increase visibility for companies listed on Nasdaq’s exchanges in Stockholm, Helsinki, Copenhagen and Iceland*.
Effective January 2, 2015, the following 24 companies will change segment. 18 companies change to a larger segment, while 6 companies change to a smaller segment.
*There were no cap segment changes on Nasdaq Iceland this year.
Company | Current Segment | New Segment |
Listing Venue |
Aerocrine AB ser B | Mid Cap | Small Cap | Stockholm |
Betsson AB ser B | Mid Cap | Large Cap | Stockholm |
Fastighets AB Balder ser B | Mid Cap | Large Cap | Stockholm |
Fastighets AB Balder pref | Mid Cap | Large Cap | Stockholm |
Black Earth Farming Ltd. SDB | Mid Cap | Small Cap | Stockholm |
HMS Networks AB | Small Cap | Mid Cap | Stockholm |
Indutrade AB | Mid Cap | Large Cap | Stockholm |
Lifco AB ser B | Mid Cap | Large Cap | Stockholm |
Loomis AB ser B | Mid Cap | Large Cap | Stockholm |
Mycronic AB | Small Cap | Mid Cap | Stockholm |
Nobia AB | Mid Cap | Large Cap | Stockholm |
Oasmia Pharmaceutical AB | Small Cap | Mid Cap | Stockholm |
Transcom WorldWide AB | Small Cap | Mid Cap | Stockholm |
VBG GROUP AB ser B | Small Cap | Mid Cap | Stockholm |
Vitrolife AB | Small Cap | Mid Cap | Stockholm |
Biotie Therapies Oyj | Mid Cap | Small Cap | Helsinki |
Citycon Oyj | Mid Cap | Large Cap | Helsinki |
Sponda Oyj | Mid Cap | Large Cap | Helsinki |
Stockmann Oyj Abp A | Large Cap | Mid Cap | Helsinki |
Stockmann Oyj Abp B | Large Cap | Mid Cap | Helsinki |
Talvivaaran Kaivososakeyhtiö Oyj | Mid Cap | Small Cap | Helsinki |
Det Østasiatiske Kompagni A/S | Mid Cap | Small Cap | Copenhagen |
Nørresundby Bank A/S | Small Cap | Mid Cap | Copenhagen |
Per Aarsleff B A/S | Small Cap | Mid Cap | Copenhagen |
Royal UNIBREW A/S | Mid Cap | Large Cap | Copenhagen |
Veloxis Pharmaceuticals A/S | Small Cap | Mid Cap | Copenhagen |
About the market cap segments
Companies belong to a market cap segment (Small-, Mid- and Large Cap) based on its average market value during the given review month. Each segment is reviewed annually based on the average market cap in Novemberwith adjustments taking effect in January the following year. The market cap calculations are based on the total number of shares, i.e. both listed and non-listed shares, of a company. Companies with a market value exceeding EUR 1 billion are in the group of “Large Cap”, while companies with a market value smaller than EUR 150 million belong to “Small Cap”. Companies with a market value between EUR 150 billion and EUR 1 billion belong to the “Mid Cap” segment.
12 month transitional period
Companies with a market cap value of more than 50 percent of the minimum or maximum threshold of each segment are transferred into the new segment with immediate effect. Companies with a market cap value of less than 50 percent of the minimum or maximum threshold of each segment are subject to a transitional period and thus one more review before transferring into the new segment. Hence, based on the EUR 1 billion Large Cap and EUR 150 million Mid Cap thresholds, a Large Cap company whose market cap value has not fallen below EUR 500 million, and a Mid-cap company whose market cap value has not fallen below EUR 75 million, are subject to a second review before moving down to the new segment. Similarly, a Mid Cap company whose market cap value has not exceeded EUR 1.5 billion and a Small-cap company whose market cap value has not exceeded EUR 225 million, are subject to a second review before moving up to the new segment.